Roundhill Glp-1 & Weight ... (OZEM)
NasdaqGM: OZEM
· Real-Time Price · USD
33.86
+0.10 (0.30%)
At close: Aug 26, 2026, 2:21 PM
Roundhill Glp-1 & Weight Loss ETF (OZEM) ETF Price, Holdings & Analysis
0.30% (1D)
| Bid | 23.33 |
| Market Cap | n/a |
| AUM | 61.38M |
| NAV | 33.80 |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 14.94 |
| Shares Out | n/a |
| Inception Date | May 20, 2024 |
| Ask | 41.71 |
| Volume | 15,278 |
| Avg. Volume (20D) | 23,491 |
| Open | 33.93 |
| Previous Close | 33.76 |
| Day's Range | 33.77 - 34.11 |
| 52-Week Range | 25.24 - 37.15 |
| Holdings | n/a |
| Expense Ratio | 0.59% |
About OZEM
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.
Asset Class Equity
Ticker Symbol OZEM
Inception Date May 20, 2024
Provider Roundhill Investments
Website Fund Home Page
Exchange NasdaqGM
Top 10 Holdings 64.59% of assets
| Name | Symbol | Weight |
|---|---|---|
| Novo Nordisk As Adr | NVO | 12.96% |
| Eli Lilly And Co | LLY | 12.36% |
| Pfizer Inc | PFE | 6.75% |
| Cspc Pharmaceutical ... | 1093.HK | 6.65% |
| Kailera Therapeutics... | KLRA | 4.86% |
| Viking Therapeutics ... | VKTX | 4.85% |
| Chugai Pharmaceutica... | 4519.T | 4.29% |
| Zealand Pharma As | ZEAL.CO | 4.22% |
| Amgen Inc | AMGN | 4.16% |
| Astrazeneca PLC | AZN.L | 3.49% |
Dividends Dividend Yield 1.21%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2025 | $0.4100 | n/a |
| Dec 30, 2024 | $0.0530 | n/a |
Page 1 of 2